Laboratory methods: A concise review and update for COVID‐19 diagnosis

Author:

Nemati Mohadeseh1ORCID,Jafari Ameneh2,Ebrahimi Yaser1ORCID,Golchin Ali1ORCID,Pouya Fahima Danesh1,Rezaei‐Tavirani Mostafa2,Rasmi Yousef13

Affiliation:

1. Department of Clinical Biochemistry, Faculty of Medicine Urmia University of Medical Sciences Urmia Iran

2. Proteomics Research Center, Faculty of Paramedical Sciences Shahid Beheshti University of Medical Sciences Tehran Iran

3. Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute Urmia University of Medical Sciences Urmia Iran

Abstract

AbstractSince late December 2019, coronavirus disease 2019 (COVID‐19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been rapidly spread across the globe. The early, safe, sensitive, and accurate diagnosis of viral infection is required to decrease and control contagious infection and improve public health surveillance. The diagnosis generally is made by detecting SARS‐CoV‐2‐related agents, including a range of nucleic acid detection‐based, immunoassay‐based, radiographic‐based, and biosensor‐based methods. This review presents the progress of various detection tools for diagnosing COVID‐19 and addresses the advantages and restrictions of each detection method. Given that diagnosis of a contagious various like SARS‐COV‐2 can improve patient survival rates and break the transmission chain, there is no surprise that significant efforts should be made to reduce the limitations of tests that lead to false‐negative results and to develop a substantial test for COVID‐19 diagnosis.

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

Reference88 articles.

1. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?

2. Review of analytical performance of COVID‐19 detection methods;Giri B;Anal Bioanal Chem,2020

3. Current and Perspective Diagnostic Techniques for COVID-19

4. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

5. Investigating the human protein‐host protein interactome of SARS‐CoV‐2 infection in the small intestine;Khodadoost M;Gastroenterol Hepatol Bed Bench,2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3